NeuroPace Overview
NeuroPace Target Price
Analysts' average 12-month price target for NeuroPace is $20.
Get informed when a big investor buys or sells
+ FollowShare Price
$13.97
Average Target Price
$20.33
45.5% upside
45.5% upside3 analysts in the last 4 months
High: $22 | Low: $18
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-17 | KeyBanc | $18 | 28.8% upside |  |
| 2026-09-15 | Raymond JamesSarah James | $21 | 50.3% upside | |
| 2026-07-23 | Mizuho Securities | $22 | 57.5% upside | |
| 2026-05-15 | H.C. Wainwright | $20 | 43.2% upside | |
| 2026-01-27 | H.C. Wainwright | $19 | 36% upside | |
| 2025-12-16 | UBS | $22 | 57.5% upside | |
| 2025-12-09 | UBSPriya Sachdeva | $18 | 28.8% upside | |
| 2025-11-05 | Leerink PartnersMike Kratky | $19 | 36% upside | |
| 2025-11-05 | Cantor FitzgeraldRoss Osborn | $16 | 14.5% upside | |
| 2024-08-14 | Wells FargoVik Chopra | $15 | 7.4% upside | |
| 2024-05-23 | Lake StreetFrank Takkinen | $20 | 43.2% upside | |
| 2024-03-14 | Wells FargoLarry Biegelsen | $20 | 43.2% upside | |
| 2023-11-10 | Cantor FitzgeraldRoss Osborn | $11 |  21.3% downside | |
| 2022-07-15 | Morgan Stanley | $5.5 | 60.6% downside | |
| 2022-05-13 | Morgan Stanley | $6 | 57.1% downside | |